Detected ·

AMR Bio

——

AMR Bio, a biotech company tackling antimicrobial resistance, raised £1.3M led by EMV Capital to advance XF-73, a Phase 3-ready antimicrobial for pre-surgical decolonisation.

Amount
—
Stage
—
Event
Funding round
Detected
2026-05-22 15:43:19 UTC
Signal ID
350384e2-1782-4cf5-b81c-65f1465827cb

As the API returns it

{
  "id": "350384e2-1782-4cf5-b81c-65f1465827cb",
  "created_at": "2026-05-22T15:43:19.255111Z",
  "company_name": "AMR Bio",
  "company_website_url": "amr-bio.com",
  "company_linkedin_url": "https://www.linkedin.com/company/amr-bio",
  "event_type": "funding",
  "funding_amount": null,
  "funding_currency": null,
  "funding_stage": null,
  "message": "*AMR Bio, a biotech company tackling antimicrobial resistance, raised £1.3M led by EMV Capital to advance XF-73, a Phase 3-ready antimicrobial for pre-surgical decolonisation.*"
}

Latest rounds